Matritech (NASDAQ - NMPS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Mueller who wrote (302)	11/8/1996 11:52:00 AM
From: Damon Pham	of 849

Keep in mind that this company currently has a R&D mentality because of where they are in their business development. If you look at their financials, the bulk of the expenses are R&D related. Don't expect a slick IR until the company starts outgrowing the R&D phase and shifts more to a sales orientation. I would be VERY worried if the company had a slick IR and PR group now since I would suspect they are hyping their stock. Buy for the long-term. The company has lots of promising looking stuff in the pipe line. It will take time (9-12 months min.) before you start seeing it pay off in terms of clinical results, FDA approval, and revenue impact. FYI, the whole bio-tech group has been left behind during the last couple days of frenzied stock rally. People are dumping this group and buying hi-tech because of the perceived better returns in the short-run.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next